Main > PSYCHIATRY > Depression > Treatment > Methylphenidate (CNS Stimulant). > Enantiomer. > (S,S)-Enantiomer. > (L-Threo-Methylphenidate). > Patent > Literature > Claim 1: Dysphoria Treat. Method. > Adm.: L-Threo-Methylphenidate > Purity > 95%. Claim 2: Oral Adm. of > Sufficient Dose such that > First Pass Metabolism is Saturated

---

First Pass Metabolism is Saturated's subsections
resulting in Therapeutically Effect

First Pass Metabolism is Saturated's products
This section has no products